期刊文献+

高级别脑内神经胶质瘤术后生存期限影响因素分析

Analysis of the influence factors for postoperative survival period of high grade brain glioma
下载PDF
导出
摘要 目的分析高级别脑内神经胶质瘤术后生存期限的影响因素。方法选择2008-01—2012-12手术治疗的Ⅲ、Ⅳ级脑内神经胶质细胞瘤256例,进行定期随访,统计术后24个月生存率,并分析其影响因素。结果Ⅲ、Ⅳ级脑内神经胶质细胞瘤患者术后24个月生存率为46.09%(118/256),小脑、直径>5cm、Ⅳ级、KPS评分<70、Ki67指数阳性、术后规范放疗脑内神经胶质瘤术后>24个月生存率明显低于大脑、直径≤5cm、Ⅲ级、KPS评分<70、Ki67指数阴性、术后不规范放疗者,差异有统计学意义(P<0.05)。肿瘤部位、肿瘤大小、病理分级、KPS评分、Ki67指数、术后辅助放疗是脑内神经胶质瘤术后生存期限独立危险因素(OR=0.529、1.048、0.179、1.798、0.886、1.046,P<0.05)。结论高级别脑内神经胶质瘤术后24个月生存率较低,发病部位、肿瘤大小、病理分级、KPS评分、Ki67指数、术后辅助放疗是其生存期限的独立危险因素。 Objective To analyze the high grade brain glioma influence factors postoperative survival period.Methods Totally 256 cases ofⅢ,Ⅳ grade brain glioma treated by operation who were followed up regularly from January 2008 to December 2012 were selected,the survival rates of postoperative 24 months were counted,and the influence factors were analyzed.Results The survival rate was 46.09%(118/256)of the Ⅲ,Ⅳ grade brain glioma patients postoperative 24-month,the brain glioma postoperative survival rate was significantly lower whose cerebellar diameter5cm,grade Ⅳ,KPS score70,Ki67 index was positive and postoperative radiotherapy was standardized than that of the brain,the diameter≤5cm,Ⅲ grade,KPS score70,Ki67 index was negative,and postoperative radiotherapy was not standardized,so the difference was statistically significant(P〈0.05).The tumor location,tumor size,pathological grade,KPS score,Ki67 index,postoperative adjuvant radiotherapy were independent risk factors(OR=0.529,1.048,0.179,1.798,0.886,1.046,P〈0.05)for survival period of brain glioma postoperative.Conclusion The survival rate is lower in high grade brain glioma patients postoperative 24-month,and the tumor size,pathological grade,KPS score,Ki67 index,postoperative adjuvant radiotherapy are independent risk factors of survival period.
出处 《中国实用神经疾病杂志》 2016年第11期19-21,共3页 Chinese Journal of Practical Nervous Diseases
关键词 高级别脑内神经胶质瘤 生存期限 影响因素 High grade brain glioma Survival period Influence factors
  • 相关文献

参考文献13

  • 1Jackson M,Bydder S,Maujean E.Radiotherapy in the manage- ment of high-grade gliomas diagnosed in Western Australia:A patterns of care study[J].J Med Imaging Radial Oncol,2012,56(1):109-115.
  • 2古丽娜尔.吐尔地,朱成斌.高级别脑胶质瘤术后不同放化疗时序及程序对无进展生存期的影响[J].中国实用神经疾病杂志,2014,17(17):16-17. 被引量:3
  • 3Wakabayashi T,Natsume A,Fujii M.Chemotherapy for malig- nant gliomas:an update[J],Gan To Kagaku Ryoho,2013,40(10):1283-1287.
  • 4Mikheev AM,Ramakrishna R,Stoll EA,et al.Increased age of transformed mouse neural progenitor stem cells recapitulates agedependent clinical features of human glioma malignancy [J].Aging Cell,2012,11(6):1027-]035.
  • 5Wakabayashi T,Natsume A,Fujii M.Chemotherapy for malig- nant gliomas:an update[J].Gan To Kagaku Ryoho,2013,40(10):1283-1287.
  • 6程毅飞.神经胶质瘤术后预后的相关因素分析[D].合肥:安徽医科大学,2011.
  • 7Ding D,Wei S,Song Y,et al.Osthole exhibits anti-cancer prop- erty in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways[J].Cell Physiol Biochem,2013,32(6):1751-1760.
  • 8Liu SY,Mei WZ,Lin ZX.Pre-operative perilumoral edema and survival rate in glioblastoma multiforme[J],Onkologie,2013,36(11):679-684.
  • 9王洪林,陈剑,朱虹,等.尼妥珠单抗联合术后同步放化疗治疗术后残留脑胶质瘤的初步研究[J].中华临床医师杂志,2013,7(6):689-692.
  • 10程毅飞,张晓东,万强,洪文清,张昊.影响神经胶质瘤术后生存的相关因素分析[J].安徽医科大学学报,2014,49(8):1171-1173. 被引量:9

二级参考文献44

  • 1翟小明,顾科,王建平,张军宁.成人脑恶性胶质瘤术后放疗同步替尼泊甙联合司莫司汀化疗疗效分析[J].中华放射医学与防护杂志,2007,27(2):152-154. 被引量:7
  • 2Valentini V,Cellini F,Minsky BD,et al.Survival after radiotherapy in gastric cancer:systematic review and meta-analysis[J]. Radiother Oncol,2009,92(2):176-83.
  • 3Qi ST,Yu L,Lu YT,et al.IDH mutations occur frequently in Chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas [J].Oncol Rep,2011,26(6):1479-85.
  • 4Stupp R,Mason WP,Van Den Bent MJ,et al.Concomitant and adjuvant temozolomide(TMZ)and radiotherapy(RT)for newly diagnosed glioblastoma multiforme(GBM):conclusive results of a randomized phaseⅢtrial by the EORT(Brain&RT Groups and NCIC Clinical Trials Group)[J].J Clin Oncol,2004,22(Suppl 14): 2-6.
  • 5Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas[J]. J Neuropathol Exp Neurol, 2005, 64 (6): 479-483.
  • 6Behin A, Hoang-Xuan K, Carpentier AF, et al. Primary brain tumours in adults[J]. Lancet, 2003, 361(9354): 323-325.
  • 7Deb P, Sharma MC, Mahapatra AK, et al. Glioblastoma multiforme with long term survival[J]. Neurol India, 2005, 53(3): 329-334.
  • 8Lutterbach J, Bartelt S, Momm F, et al. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases [J]. Cancer, 2005, 103(6): 1234-1238.
  • 9Shinojima N, Kochi M, Hamada J, et al. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme [J]. J Neurosurg, 2004, 101(2): 219-223.
  • 10Jeremic B, Milicic B, Grujicic D, et al. Clinical prognostic factors in patients with malignant glioma treated with combined modality approach[J]. Am J Clin Oncol, 2004, 27(2): 195-199.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部